It will be interesting to see how HITI's USA strategy will play out, the comments were skeptical as they feel the US is a mature and very different market. The key point they made was HITI will need to be a producer of it's own MJ to compete with the margins in the US. I think there is some merit to that on the medical side, that HITI does not participate in, but I think that is a short
...more